WHO-UMC IDMP Management and Publish API, published by Uppsala Monitoring Centre. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/Uppsala-Monitoring-Centre/WHO-UMC-IDMP-Service/ and changes regularly. See the Directory of published versions
Generated Narrative: Task UK-emc-00001
status: Draft
intent: proposal
priority: Routine
authoredOn: 2024-01-17
lastModified: 2024-01-17
input
type: Medicinal Product for PhPID request
input
type: Ingredient for PhPID request
input
type: Test by Datapharm for PhPID request
Generated Narrative: MedicinalProductDefinition #5d02cfc1-053f-4694-9ce8-d0ee6c658b72
identifier:
http://medicines.org.uk/product
/511type: Medicinal Product
domain: Human use
status: Active
statusDate: 2020-08-03 15:11:41+0000
combinedPharmaceuticalDoseForm: Tablet and powder for oral solution
classification: methotrexate
attachedDocument: SPC/511
Contacts
Contact Organization Datapharm Test Inc name
productName: Methotrexate 2.5 mg Tablets
type: RegulatorApprovedName
Usages
Country Jurisdiction Language United Kingdom United Kingdom English
Generated Narrative: Ingredient #54c6c580-5b34-4032-9403-c9d2154ac073
status: Active
role: Active
substance
Codes
Concept Methotrexate sodium Strengths
Presentation[x] TextPresentation 2.5 milligram (Details: UCUM codemg = 'mg')/1 IU (Details: Strength units applicable in the IDMP PhPID service codeIU = 'arbitrary international unit') 2.5 mg
Generated Narrative: Organization #dti
active: true
type: Datapharm Test FCAT35
name: Datapharm Test Inc